The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation
NCT00181142
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Patients Active and Listed for Lung Transplantation
Interventions
DRUG:
Zenapax
Sponsor
Johns Hopkins University